Fennec Pharmaceuticals

FENC52

$5.32arrow_drop_up12.71%$0.60

FENC52

$5.32

arrow_drop_up12.71%$0.60

Performance History

Key Stats
Open	$4.68
Prev. Close	$4.72
EPS	-0.04
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$145.93M
PE Ratio	-

	LOW	HIGH
Day Range	4.68	5.55
52 Week Range	3.80	11.92

Ratios







EPS	-0.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc (FENC) is a pharmaceutical company focused on the development of innovative cancer therapies. With a strong commitment to improving patient outcomes, Fennec is dedicated to advancing its pipeline of drugs that target unmet medical needs. FENC has a proven track record of bringing game-changing therapies to market, and its stock price history reflects this success. The company's stock has shown consistent growth over the years, making it an attractive investment option for those looking to capitalize on the booming healthcare sector.

As of the latest quote, FENC stock is trading at a favorable price, making it an opportune time to consider investing. The stock has been attracting attention from investors due to the positive news surrounding the company. Fennec Pharmaceuticals recently announced positive clinical trial results for one of its lead drug candidates, which has sparked excitement and optimism among shareholders. This news has contributed to the overall positive sentiment surrounding FENC stock and has potential to drive further price appreciation.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Rostislav Raykov
Headquarters: Research Triangle Park
Employees: 36
Exchange: NASDAQ

Keep an eye on Fennec Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Fennec Pharmaceuticals 's (FENC) price per share?

The current price per share for Fennec Pharmaceuticals (FENC) is $5.32. The stock has seen a price change of $0.6 recently, indicating a 12.71% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Fennec Pharmaceuticals (FENC)?

For Fennec Pharmaceuticals (FENC), the 52-week high is $11.92, which is 124.06% from the current price. The 52-week low is $3.81, the current price is 39.82% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Fennec Pharmaceuticals (FENC) a growth stock?

Fennec Pharmaceuticals (FENC) has shown an average price growth of -4.13% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Fennec Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Fennec Pharmaceuticals (FENC) stock price performance year to date (YTD)?

As of the latest data, Fennec Pharmaceuticals (FENC) has a year-to-date price change of -52.16%. Over the past month, the stock has experienced a price change of 17.18%. Over the last three months, the change has been -3.27%. Over the past six months, the figure is -26.01%. Looking at a longer horizon, the five-year price change stands at -8.59%.

help

Is Fennec Pharmaceuticals (FENC) a profitable company?

Fennec Pharmaceuticals (FENC) has a net income of -$16.04M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 94.08% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -74.59% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $21.25M, although specific revenue growth data is currently not available. The gross profit is $19.99M. Operating income is noted at -$12.77M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Fennec Pharmaceuticals (FENC)?

Fennec Pharmaceuticals (FENC) has a market capitalization of $145.94M. The average daily trading volume is 5.3, indicating the stock's liquidity and investor engagement.